PUBLISHER: Grand View Research | PRODUCT CODE: 1888600
PUBLISHER: Grand View Research | PRODUCT CODE: 1888600
The global brain health supplements market size was estimated at USD 10.95 billion in 2024 and is projected to reach USD 23.52 billion by 2030, growing at a CAGR of 13.7% from 2025 to 2030. The market growth can be attributed to rising awareness regarding mental health issues, such as lack of attention and focus, declining memory, and heightened anxiety and depression.
Moreover, the increasing adoption of natural and herbal health products is anticipated to fuel the industry's growth over the forecast period. Rising demand for multi-efficacy drugs that work as energy boosters, antidepressants, brain enhancers, and resist anxiety is expected to drive greater R&D activities in this industry. Moreover, increasing demand by the sports industry to improve the brain efficacy of players is also expected to generate growth opportunities for the global market. Individuals associated with academic and professional arenas are expected to contribute to the demand for the brain health supplements industry over the next few years. In addition, these products are likely to gain high acceptance among people suffering from various brain ailments such as depression, dementia, anxiety, and insomnia, to name a few.
As of March 2023, the World Health Organization (WHO) reported that approximately 3.8% of the global population suffers from depression, with this figure rising to 5% among adults, 4% for men, and 6% for women, and reaching 5.7% in adults over the age of 60. Depression affects approximately 280 million individuals globally, making it a widespread mental health condition. Increasing awareness about mental illnesses is expected to widen the scope of application for brain health supplements in the near future.
Moreover, the supplements are employed for the treatment of other cognitive and age-related disorders, including hyperactivity and Parkinson's disease. Growing concern regarding mental health wellness and cognitive development is expected to augment the growth of the global brain health supplements market.
A wide variety of supplements are available that support brain health and help lower the risk of neurodegenerative conditions such as Alzheimer's disease and dementia. While these supplements have potential to prevent certain disorders, concerns remain regarding their safety and effectiveness. Some marketed brain health supplements may include undeclared ingredients on the nutrition label or present inaccurate dosages. Additionally, overconsumption can expose individuals to adverse effects.
To address these issues, researchers are increasingly working on the development of new extracts and ingredients that are both safe and effective for consumers. Manufacturers, in turn, are emphasizing securing regulatory approval to gain marketing authorization. For instance, in August 2023, AKER BIOMARINE, a biotechnology innovator, received new dietary ingredient status from the U.S. FDA for LYSOVETA, a brain health ingredient designed to mitigate cognitive decline associated with aging.
This approval enabled the company to market the product to the general adult population. Introducing novel ingredients is expected to drive significant growth in the brain health supplements market.
Global Brain Health Supplements Market Report Segmentation
This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global brain health supplements market based on product, form, application, distribution channel, and region.